Barclays’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
BCM
Barclays's IMA Position: Q3 2026 in Review
Barclays held its ImageneBio (IMA) position steady in Q3 2026 at 10,797 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4575.
Barclays first reported a position in IMA in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.33M in Q2 2023. 27 funds tracked by Wall St. Rank hold IMA as of Q3 2026.
- Barclays held 10,797 shares of ImageneBio worth $49.4K as of Q3 2026.
- Barclays left its ImageneBio share count unchanged in Q3 2026.
- ImageneBio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4575 holding.
- Barclays first reported a position in ImageneBio in Q1 2022 and has held it in 19 quarters since.
- Barclays's ImageneBio position peaked at $1.33M in Q2 2023.
- 27 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.